A lot of things are different when you’re in the midst of a global pandemic. A case in point: How federal regulators scrutinize and authorize new vaccines.

The U.S. Food and Drug Administration ushered in a new phase of the fight against COVID-19 on Friday by giving its blessing to a vaccine made by Pfizer Inc. and BioNTech. It’s the first such vaccine to get a green light from the FDA, and immunizations will begin in a matter of days.

There are plenty of reasons why it passed muster. Clinical trial data indicate that:

• It was 95% effective at preventing cases of COVID-19 in both Latinos and non-Latinos.

• It was 100% effective in Black people.

• …continued .
[Source: CNBC News]